Patients with Crohn’s disease are more likely to remain on biologics than immunomodulators: a meta-analysis of treatment durability.

Citation:
Shah ED, Siegel CA, Chong K, et al. Patients with Crohn’s disease are more likely to remain on biologics than immunomodulators: a meta-analysis of treatment durability. Dig Dis Sci 2015;60(8):2408–18. PMID: 25772778.
Principal Investigator: 
Document Type: 
Medical Condition: